• Wed, May 23, 2018
  • Thu, May 24, 2018
  • Fri, May 25, 2018

Alex Arfaei Maintained (ABBV) at Sell with Decreased Target to $78 on, May 23rd, 2018

Alex Arfaei of BMO Capital, Maintained "AbbVie Inc." (ABBV) at Sell with Decreased Target from $81 to $78 on, May 23rd, 2018.

Alex has made no other calls on ABBV in the last 4 months.



There are 4 other peers that have a rating on ABBV. Out of the 4 peers that are also analyzing ABBV, 3 agree with Alex's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Vamil Divan of "Credit Suisse" Maintained at Hold with Decreased Target to $104 on, Friday, April 27th, 2018
  • Geoff Meacham of "Barclays" Maintained at Hold with Decreased Target to $102 on, Thursday, April 5th, 2018
  • Geoffrey Porges of "Leerink Swann" Downgraded from Buy to Hold on, Monday, January 29th, 2018


This is the rating of the analyst that currently disagrees with Alex


  • David Toung of "Argus Research" Maintained at Strong Buy with Increased Target to $145 on, Friday, February 2nd, 2018